ArticleJournal of cancer research and clinical oncology2022

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.

Hana Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.